Listed Healthcare Companies Create Nearly 80,000 Jobs, Expanding Headcount by 48% Since 2019
A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000…
Fleury is a diagnostic medicine group with laboratories and clinics across Brazil.
FLRY3 is the ticker of Fleury’s common shares (ON) on B3, listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Company facts: CVM open data (Formulário Cadastral 2026), available under the ODbL. Descriptions by Brazil Stock Guide.
A BTG Pactual survey shows ten listed healthcare companies increased their combined workforce from about 166,000…
Company seeks waiver to avoid technical default while negotiating restructuring with Porto and Fleury under liquidity…
Shareholder says proposed NewCo is too complex and fails to address urgent liquidity needs.
Non-binding deal outlines NewCo structure with R$2.5 billion in liabilities as creditors prepare to vote.
Revenue climbs 12% year-on-year while EBITDA reaches R$455.9 million, supported by B2C expansion and acquisitions.
Executives highlight strong pipeline but reject overpaying as company balances growth with low leverage and cash…
Diagnostic group gains market share as flagship brand and regional units drive expansion.
Transaction strengthens regional network and requires no shareholder vote.
Company responds to regulator after report on potential acquisitions
FLRY3 is the ticker of Fleury’s common shares (ON) on B3, the São Paulo stock exchange, where the company is listed in the Novo Mercado, the segment with B3’s strictest corporate-governance rules.
Yes. Non-resident investors can buy shares listed on B3 through a Brazilian custodian after registering with the CVM, the Brazilian securities regulator.
The quote, chart, technical rating, company profile and financials on this page are TradingView widgets with B3 market data. The company facts come from the CVM public register, and the news from the Brazil Stock Guide newsroom.
Market data by TradingView. Informational only — not investment advice.